Deltagen Inc (DGEN) 0.0020 $DGEN
Mice Model Market (Model Type, Specialty, Services, and Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
M2 - Fri Oct 02, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7xrl2c/mice_model_market) has announced the addition of the "Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023" report to their offering. The global mice model market was valued at USD 1,008.1 million in 2014 and is projected to reach USD 1,749.3 million in 2023, expanding at a CAGR of 6.4% from 2015 to 2023. Major factor boosting the growth of the market is the growing application of mice models not only in the field of basic research, but also in applied field of drug development and discovery. Development of mice models of human diseases has progressed rapidly in the past few years. Mice model has become indispensable in the evaluation of established and experimental treatment strategies, especially in cancer, cardiovascular diseases, metabolic anomalies, and neurological disorders. Mice model applications in drug discovery include development of new therapeutic strategies for the treatment of human diseases, target identification and validation, drug screening and lead optimization, and toxicity and safety screening. Furthermore, advancements in genetic engineering assisting in evaluating drug mechanism of action and its responses are expected to impact the growth of the drug discovery market. On the other hand, factors such as stringent regulatory framework that require precise control on use of animals in laboratories, rising concern on animal cruelty, and ethical concerns over the use of animals could negatively impact market growth. The mice model market has been segmented into three major categories: model type, specialty, and services. Based on model type, inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Metabolic & regulatory diseases was the largest specialty segment of the mice model market in terms of revenue in 2014. The segment accounted for 29.6% share of the market in 2014. The mice model services market is anticipated to expand at a CAGR of 7.3% from 2015 to 2023. The cryopreservation and cryorecovery services segment would expand at the highest growth rate during the forecast period as it requires less investment to maintain mice strain for a longer time. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Mice Model Market: Market Overview Chapter 4 Global Mice Model Market, by Type Chapter 5 Global Mice Model Market, by Specialty Chapter 6 Global Mice Model Market, by Services Chapter 7 Global Mice Model Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles - Charles River Laboratories - Crescendo Biologics Limited - Deltagen Inc. - GenOway S.A. - Harlan Laboratories Inc. - ImmunoGenes AG - Lexicon Pharmaceuticals - SAGE Labs - Taconic Biosciences Inc. - Taconic Biosciences Inc. - The Jackson Laboratory - TransGenic Inc. For more information visit http://www.researchandmarkets.com/research/7x...del_market
LXRX: 15.95 (+0.02)
Deltagen Reports 2014 Full Year Financial Results
BusinessWire - Mon Mar 23, 11:00AM CDT
Deltagen, Inc. (Pink Sheets: DGEN), a provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the year ended December 31, 2014.
Mice Model Market (Model Type, Specialty, Services, and Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
M2 - Fri Oct 02, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7xrl2c/mice_model_market) has announced the addition of the "Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023" report to their offering. The global mice model market was valued at USD 1,008.1 million in 2014 and is projected to reach USD 1,749.3 million in 2023, expanding at a CAGR of 6.4% from 2015 to 2023. Major factor boosting the growth of the market is the growing application of mice models not only in the field of basic research, but also in applied field of drug development and discovery. Development of mice models of human diseases has progressed rapidly in the past few years. Mice model has become indispensable in the evaluation of established and experimental treatment strategies, especially in cancer, cardiovascular diseases, metabolic anomalies, and neurological disorders. Mice model applications in drug discovery include development of new therapeutic strategies for the treatment of human diseases, target identification and validation, drug screening and lead optimization, and toxicity and safety screening. Furthermore, advancements in genetic engineering assisting in evaluating drug mechanism of action and its responses are expected to impact the growth of the drug discovery market. On the other hand, factors such as stringent regulatory framework that require precise control on use of animals in laboratories, rising concern on animal cruelty, and ethical concerns over the use of animals could negatively impact market growth. The mice model market has been segmented into three major categories: model type, specialty, and services. Based on model type, inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Metabolic & regulatory diseases was the largest specialty segment of the mice model market in terms of revenue in 2014. The segment accounted for 29.6% share of the market in 2014. The mice model services market is anticipated to expand at a CAGR of 7.3% from 2015 to 2023. The cryopreservation and cryorecovery services segment would expand at the highest growth rate during the forecast period as it requires less investment to maintain mice strain for a longer time. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Mice Model Market: Market Overview Chapter 4 Global Mice Model Market, by Type Chapter 5 Global Mice Model Market, by Specialty Chapter 6 Global Mice Model Market, by Services Chapter 7 Global Mice Model Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles - Charles River Laboratories - Crescendo Biologics Limited - Deltagen Inc. - GenOway S.A. - Harlan Laboratories Inc. - ImmunoGenes AG - Lexicon Pharmaceuticals - SAGE Labs - Taconic Biosciences Inc. - Taconic Biosciences Inc. - The Jackson Laboratory - TransGenic Inc. For more information visit http://www.researchandmarkets.com/research/7x...del_market
LXRX: 15.95 (+0.02)
Deltagen Reports 2014 Full Year Financial Results
BusinessWire - Mon Mar 23, 11:00AM CDT
Deltagen, Inc. (Pink Sheets: DGEN), a provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the year ended December 31, 2014.
